INSPECS Group plc (AIM:SPEC)
London · Delayed Price · Currency is GBP · Price in GBX 42.52
-0.48 (-1.12%)
Sep 9, 2025, 1:49 PM GMT+1
INSPECS Group Market Cap
INSPECS Group has a market cap or net worth of 43.72 million as of September 9, 2025. Its market cap has decreased by -18.10% in one year.
Market Cap
43.72M
Enterprise Value
82.23M
Revenue
198.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
42.52
Market Cap Chart
Since February 27, 2020, INSPECS Group's market cap has decreased from 137.95M to 43.72M, a decrease of -68.31%. That is a compound annual growth rate of -18.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 43.72M | -5.49% |
| Dec 31, 2024 | 46.26M | -45.83% |
| Dec 29, 2023 | 85.40M | 95.35% |
| Dec 30, 2022 | 43.72M | -88.33% |
| Dec 31, 2021 | 374.78M | 12.12% |
| Dec 31, 2020 | 334.26M | 142.30% |
| Feb 27, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 187.48B |
| GSK plc | 59.44B |
| Haleon | 32.74B |
| Smith & Nephew | 12.30B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.81B |
| HUTCHMED (China) | 2.01B |
| Genus | 1.76B |